Secured Research | Equipment Finance Originator | Monitor | Monitor Suite | Converge | STRIPES Leadership
No Result
View All Result
ABF Journal
Forward for Specialty Finance
SUBSCRIBE
Lender & Services Directory
  • News
    • People
    • Economy
    • All News
  • Deals
  • Magazine
    • Magazine Issues
    • Nominations
  • Features
    • Articles & Insights
    • Resolving MCA Distress
    • Resolving Business Distress
  • Events
  • Recruiting
    • Molloy Associates Senior Asset Based Lending Originator Location: Remote
  • Advertise
  • Contact Us
  • News
    • People
    • Economy
    • All News
  • Deals
  • Magazine
    • Magazine Issues
    • Nominations
  • Features
    • Articles & Insights
    • Resolving MCA Distress
    • Resolving Business Distress
  • Events
  • Recruiting
    • Molloy Associates Senior Asset Based Lending Originator Location: Remote
  • Advertise
  • Contact Us
No Result
View All Result
ABF Journal
No Result
View All Result
Home Deal Announcements

Oxford Finance Provides $45MM Senior Secured Loan Facility to CENTOGENE

byIan Koplin
February 1, 2022
in Deal Announcements

CENTOGENE, a commercial-stage company focused on generating data-driven insights to diagnose, understand and treat rare diseases, closed a €15 million ($16.9 million) private placement financing from investors led by DPE Deutsche Private Equity, TVM Capital Life Science and Careventures, as well as the entry into a $45 million senior secured loan facility provided by Oxford Finance, a specialty finance firm providing senior debt to life sciences and healthcare companies.

“We are very pleased to report today that we have secured a strong financial foundation for CENTOGENE, which will fuel our advancement on our path towards significant value creation,” Kim Stratton, CEO of CENTOGENE, said. “We are now looking forward to expeditiously delivering on the promise of strong growth in our core business in 2022 and strengthening CENTOGENE’s position as the unique and essential partner for patients, physicians and biopharma in rare, metabolic and neurodegenerative diseases.”

“This significant capital infusion will not only strengthen our balance sheet, but also allow us to accelerate growth and innovation and to deliver on some exciting, future value inflection milestones as outlined in our strategic plan,” René Just, CFO of CENTOGENE, said. “This financing is the result of CENTOGENE management’s and its Supervisory Board’s comprehensive review of a wider range of financial and strategic options. Having taken all aspects into consideration and diligently addressing the financing need, we are convinced this solution maximizes the value to our stakeholders. Additionally, the debt financing minimizes dilution to our shareholders and the dual tranche structure increases our financial flexibility.”

“CENTOGENE has built a strong position in the field of rare, metabolic, and neurodegenerative diseases by providing precise medical diagnosis at the earliest possible moment,” Christopher A. Herr, senior managing director at Oxford Finance, said. “Through this partnership, the company is positioned to continue generating leading edge medical insights and broaden its set of biopharma and pharmaceutical partners globally.”

Moelis & Company served as CENTOGENE’s financial advisor in connection with the financings.

Previous Post

Access Capital Provides $400K Credit Facility to Intero

Next Post

Cerebro Capital Provides $14.5MM to Two Clients

Related Posts

Deal Announcements

Assembled Brands Delivers $12.5MM Revolving Credit Facility to Sports Nutrition and Energy Drink Company

November 16, 2026
Deal Announcements

eCapital Provides $10MM ABL Facility to Support Food Manufacturer’s Growth

November 16, 2026
Deal Announcements

Ameresco Secures $125MM Nuveen Facility for European Growth

November 16, 2026
Wingspire Capital Provides Over $500MM in Corporate Finance Commitments in H1/25
Deal Announcements

Hedaya Capital Facility Supports Operations for Growing California 3PL Company

November 16, 2026
Deal Announcements

Peak 10 Energy Secures $500MM Acquisition Finance Facility with U.S. Bank

November 12, 2026
Deal Announcements

Exus Renewables North America Secures $345MM Financing Led by Goldman Sachs Alternatives

November 12, 2026
Next Post

Cerebro Capital Provides $14.5MM to Two Clients

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

About Us

For over 50 years, RAM Holdings’ brands have led the commercial finance industry in publishing, talent development, research and events. ABF Journal’s audience is comprised of as many as 18,000 specialty finance industry executives, private equity investors, investment bankers, advisors, service providers and more.

Our Brands

  • Secured Research
  • Equipment Finance Originator
  • Monitor
  • Monitor Suite
  • Converge
  • STRIPES Leadership

 

Learn More

  • Advertise
  • Magazine
  • Contact Us

Newsletter

Driving specialty finance forward for decades with insights, recognition and deals. Sign up now.

SUBSCRIBE >>

© 2025 RAM Group Holdings - A Leading Commercial Finance Publishing Group For Over 50 Years

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • News
    • People
    • Economy
    • All News
  • Deals
  • Features
    • Articles & Insights
    • Resolving MCA Distress
    • Resolving Business Distress
  • Magazine
    • Magazine Issues
    • Nominations
  • Molloy Associates
    • Molloy Associates Senior Asset Based Lending Originator Location: Remote
  • Events
  • Advertise
  • Contact Us
Provider Directory >>

© 2025 RAM Group Holdings - A Leading Commercial Finance Publishing Group For Over 50 Years